What is Bihar doing to eliminate lymphatic filariasis?

Bihar is conducting an 18-day Mass Drug Administration (MDA) campaign, aiming to administer anti-filarial medicines to 8.97 crore people across 34 districts.

Why is managing adverse drug reactions important in Bihar's filariasis campaign?

Managing adverse drug reactions is crucial for maintaining public confidence and ensuring high drug uptake during the Mass Drug Administration (MDA) campaign.

How can lymphatic filariasis transmission be reduced in Bihar?

Taking anti-filarial medication once a year for five consecutive years can significantly reduce disease transmission in Bihar.

Home / Health / Bihar Fights Filariasis: 8.97 Crore Targeted!

Bihar Fights Filariasis: 8.97 Crore Targeted!

9 Feb

•

Summary

Bihar launches an 18-day campaign to treat 8.97 crore people.
Managing adverse drug reactions is crucial for public confidence.
Yearly medication for five years can significantly reduce transmission.

Bihar Fights Filariasis: 8.97 Crore Targeted!

Bihar is embarking on a significant public health initiative with an 18-day Mass Drug Administration (MDA) campaign to combat lymphatic filariasis. This effort aims to reach approximately 8.97 crore individuals across 34 of the state's 38 districts, commencing on Tuesday and concluding on February 28. The campaign's success hinges on effectively managing potential adverse drug reactions (ADRs) to sustain public confidence and ensure maximum participation.

Anti-filarial medicines, including Albendazole, Diethylcarbamazine (DEC), and Ivermectin, will be administered under supervision. While reactions like nausea and headache are generally mild, they can deter people from taking the drugs. Special mega camps are planned, including one on February 11 targeting 2 crore doses for members of women's self-help groups. Trained teams will conduct household visits to ensure supervised consumption, with special school booths planned for the final three days.